Product correctly added to cart.

discount label
Gemcitabine 5'-elaidate
View 3D

Biosynth logo

Gemcitabine 5'-elaidate

CAS: 210829-30-4

Ref. 3D-NC05399

1gTo inquire
200mgTo inquire
300mgTo inquire
500mgTo inquire
Estimated delivery in United States, on Tuesday 2 Jul 2024

Product Information

Name:
Gemcitabine 5'-elaidate
Synonyms:
  • (E)-((2R,3R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-4,4-difluoro-3-hydroxytetrahydrofuran-2-yl)methyl octadec-9-enoate2'-Deoxy-2',2 '-difluorocytidine 5'-(9E)-9-octadecenoateCP-4126LVT derivative of GemcitabineCO-101
Description:

Gemcitabine 5'-elaidate is an analog of gemcitabine that has hydrophobic properties. It has been shown to be active against solid tumours, including lung cancer. In a study on murine xenografts, gemcitabine 5'-elaidate was found to have the same degree of efficacy as gemcitabine in reducing tumour growth and increasing survival time. Gemcitabine 5'-elaidate also has good antitumour activity against infectious diseases such as HIV and malaria, which may be due to its ability to bind to the epidermal growth factor receptor (EGFR) on the surface of cells. This binding prevents EGFR from initiating cellular signaling.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
527.66 g/mol
Formula:
C27H43F2N3O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-NC05399 Gemcitabine 5'-elaidate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".